Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulators.

P D Reuman1

  • 1Clinical Research, Children's Hospital Medical Center of Akron, OH, USA.

The Pediatric Infectious Disease Journal
|October 20, 2001
PubMed
Summary
This summary is machine-generated.

Cytokine immunomodulators like interferon-alpha and TNF antagonists offer therapeutic benefits for viral infections, neutrophil disorders, and rheumatoid arthritis. Ongoing research explores new cytokine-based treatments and their potential risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group.

The Pediatric infectious disease journal·1997
Same author

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults.

Vaccine·1997
Same author

Recovery from rhinocerebral mucormycosis with carotid artery occlusion: a pediatric case and review of the literature.

The Pediatric infectious disease journal·1997
Same author

Developments in childhood immunization.

Current problems in pediatrics·1996
Same author

Cord blood may be inappropriate for sensitive assays.

The Pediatric infectious disease journal·1995
Same author

Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children.

The Pediatric infectious disease journal·1993
Same journal

A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings.

The Pediatric infectious disease journal·2026
Same journal

Model-based Differentiation Between Kawasaki Disease and MIS-C: The Importance of the Mitral Valve.

The Pediatric infectious disease journal·2026
Same journal

Pulmonary Embolism in Invasive Salmonella Infection: A Rare Cause of Acute Respiratory Failure in an Adolescent.

The Pediatric infectious disease journal·2026
Same journal

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same journal

Determinants of Severity in Pediatric Viral Lower Respiratory Tract Diseases From Emergency Department Presentation to Hospital Course.

The Pediatric infectious disease journal·2026
Same journal

Oropharyngeal Colonization by Kingella kingae and Septic Arthritis in Children 6-48 Months of Age: A Portuguese Multicenter Case-control Study.

The Pediatric infectious disease journal·2026
See all related articles

Area of Science:

  • Immunology and Pharmacology
  • Biomedical Research

Background:

  • Cytokine immunomodulators are significant in medicine.
  • Interferon-alpha is used for viral infections.
  • Interferon-gamma stimulates neutrophils.
  • TNF antagonists treat rheumatoid arthritis.
  • Hemopoietic growth factors aid chemotherapy patients.

Purpose of the Study:

  • To review the clinical applications and research of cytokine immunomodulators.
  • To highlight the therapeutic uses and risks of specific cytokines.

Main Methods:

  • Literature review of clinical applications and research on cytokines.
  • Analysis of therapeutic benefits and risks associated with cytokine use.

Main Results:

Related Experiment Videos

  • Interferon-alpha demonstrates broad clinical utility against viruses.
  • Interferon-gamma shows efficacy in neutrophil disorders.
  • TNF antagonists are effective for rheumatoid arthritis but pose risks.
  • Hemopoietic growth factors benefit patients on chemotherapy.

Conclusions:

  • Cytokine immunomodulators have diverse clinical applications.
  • Research and development in cytokines and their antagonists are ongoing.
  • Balancing therapeutic benefits with potential risks is crucial.